Go Symbol Lookup
Loading...

IRS Official Lois Lerner Placed on Administrative Leave

Buffett's Cancer Scare Has Doug Kass Rethinking Berkshire

 Text Size  
Published: Tuesday, 17 Apr 2012 | 7:25 PM ET
Lee Brodie By:

Producer

On Tuesday, investors were trying to digest a late announcement that Warren Buffett had been diagnosed with prostate cancer.

According to a Berkshire Hathaway press release, Buffett has been diagnosed with stage 1 prostate cancer and will begin a 2-month course of treatment of daily radiation

Strategic investor Doug Kass is long Berkshire and tells Fast Money that these developments are leading him to rethink his position.

Doug Kass Assesses Berkshire Hathaway
In light of Warren Buffett's prostate cancer diagnosis, Doug Kass, Seabreeze Partners, offers insight on the health of Berkshire Hathaway.

"The problem with this announcement is that the calculation of the company’s intrinsic value is impacted. The upside reward is now reduced," he says.

In other words, the market didn’t know yesterday that Buffett was ill and today it does.

“Valuations must now be adjusted,” Kass says. "The premium accorded in the marketplace for Buffett must be reduced because there is an unknown now."

And Kass is putting his money where his mouth is. "I actually sold a little stock in the after market. I now want to revisit all my calculationS."

What do you think? We want to know!





______________________________________________________
Got something to to say? Send us an e-mail at fastmoney-web@cnbc.com and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment, but not have it published on our Web site, send those e-mails to fastmoney@cnbc.com.


Trader disclosure: On April 17, 2012 , the following stocks and commodities mentioned or intended to be mentioned on CNBC’s "Fast Money" were owned by the "Fast Money" traders; Karen Finerman owns HPQ; Joe Terranova owns IBM; Guy Adami owns INTC

For Brian Kelly
Nothing to disclose

For Ken Sena
Nothing to Disclose

For Saw Wu
Sterne, Agee & Leach, Inc. makes a market in the following subject company: IBM
Sterne, Agee & Leach, Inc.’s research analysts receive compensation that is based upon various factors, including Sterne, Agee & Leach, Inc.’s total revenues, a portion of which is generated by investment banking activities.
Sterne Agee & Leach, Inc. expects to receive or intends to seek compensation for investment banking services from the subject company and/or companies in the next three months: IBM

CNBC.com with wires.

 Print
"I actually sold a little Berkshire stock in the after market," Doug Kass tells us. "I want to revisit all my calculations."
  Price   Change %Change
BRK.A ---

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured

Contact Fast Money

  • Showtimes

    Halftime Report - Weekdays 12p ET
    Fast Money - Weekdays 5p ET
  • Lee is host on CNBC's “Fast Money,” and “Options Action.”

  • Wapner is an award-winning reporter and the host of "Fast Money Halftime Report." He has also reported documentaries for CNBC.

  • Adami is a contributor on CNBC's "Fast Money." He is also Managing Director of stockMONSTER.com.

  • Najarian, the "Pit Boss," is cofounder of optionMONSTER.com, a news site for options traders.

  • Finerman is President of Metropolitan Capital Advisors, Inc., a company she co-founded.

  • Founder of EmergingMoney.com

  • Chief Market Strategist for Virtus Investment Partners & CNBC Contributor

Halftime Report

Fast Money Features